Ozagrel Na intravenous infusion 40mg “Chemifa”, manufactured by Nippon Pharmaceutical Industry, contains sodium ozagrel, a thromboxane A2 synthetase inhibitor. This medication, with YJ code 3999411A6078 and standard 40mg 2mL 1 tube, is indicated for improving cerebral circulation.
Ozagrel Na intravenous infusion 40mg “Chemifa”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
